Notice NOT-OH-19-001 from the NIH Guide for Grants and Contracts

Notice NOT-NS-19-041 from the NIH Guide for Grants and Contracts

Notice NOT-ES-19-010 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-AI-19-017 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to accelerate the development and validation of sample sparing assays that can be applied for studying the human immune system in health and disease. Development of new, cutting-edge sample sparing assays will lead to maximum use of the human-derived specimens by significant reduction of sample volumes/amounts required or by simultaneous multi-parameter assessments of immune function.

Funding Opportunity RFA-CA-19-038 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to invite exploratory/developmental research grant applications (R21) for the development of innovative methods and algorithms in biomedical computing, informatics, and data science addressing priority needs across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology, and/or cancer health disparities. As a component of the NCI's Informatics Technology for Cancer Research (ITCR) Program, this FOA encourages applications focused on the development of novel computational, mathematical, and statistical algorithms and methods that can considerably improve acquisition, management, analysis, and dissemination of relevant data and/or knowledge. The central mission of ITCR is to promote research-driven informatics technology across the development lifecycle to address priority needs in cancer research. In order to be successful, there must be a clear rationale for how the proposed informatics method or algorithm is novel and how it will benefit the cancer research field. Potential applicants who are interested in downstream technology development, from prototyping to hardening and adaptation, should consult the other companion FOAs listed above.

Notice NOT-HL-19-687 from the NIH Guide for Grants and Contracts

Notice NOT-CA-19-037 from the NIH Guide for Grants and Contracts

Notice NOT-OD-19-087 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-HG-19-012 from the NIH Guide for Grants and Contracts. National Human Genome Research Institute (NHGRI) is soliciting grant applications for the support of Centers of Excellence in Ethical, Legal and Social Implications (ELSI) Research (CEERs). The CEER Program is designed to support the establishment of sustainable trans-disciplinary research teams with the expertise and flexibility to anticipate, conduct research on, and quickly address a range of cutting edge ethical, legal, and social issues related to genetics and genomics. The Program is intended to create new research opportunities that cross disciplinary boundaries among investigators in diverse fields, such as the genomic sciences, clinical research, clinical and health policy, ethics, law, the humanities, economics, political science, anthropology and other social sciences. In addition to conducting trans-disciplinary research, Centers will disseminate their research findings as well as facilitate the use of their findings to develop relevant research, health and public policies and practices. Finally, Centers will contribute to developing the next generation of ELSI researchers. The NHGRI plans to maintain the CEER program at approximately its current level of funding through FY 2023. This FOA is being issued as a limited competition RFA. Only currently funded CEERs are eligible to compete for their final four-year renewal. Applications for new CEERs will not be accepted under this FOA.

Funding Opportunity RFA-CA-19-035 from the NIH Guide for Grants and Contracts. The goal is this Funding Opportunity Announcement (FOA) is to support research on survivors of adult onset cancers who are transitioning to follow-up care. Through this FOA, the National Cancer Institute (NCI) intends to stimulate the scientific development of innovative healthcare provider- and healthcare system-level interventions to optimize outcomes. This FOA requests applications that develop and test interventions that foster strong collaborations between oncology and non-oncology providers to optimize follow-up care for adult cancer survivors. Interventions focused on the needs of racial/ethnic minority and medically underserved adult survivors, and/or those receiving care in community settings is of high priority.

Notice NOT-RM-19-005 from the NIH Guide for Grants and Contracts

Notice NOT-AI-19-052 from the NIH Guide for Grants and Contracts

Notice NOT-OD-19-092 from the NIH Guide for Grants and Contracts

Notice NOT-AG-19-014 from the NIH Guide for Grants and Contracts

Notice NOT-AG-19-013 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-DK-18-512 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites one application from the Program Director/Principal Investigator (PD/PI) of the current Data Coordinating Center (DCC) for The Environmental Determinants of Diabetes in the Young (TEDDY) study, an ongoing epidemiological study. This DCC has been involved in study design and data and bio sample acquisition and management since the inception of the TEDDY Consortium.This FOA provides support for the TEDDY DCC to continue to follow TEDDY children and allows funding for collaborators to conduct studies on integration of various omics data and the measurement and analysis of viral antibodies using samples from TEDDY subjects.

Notice NOT-HL-19-689 from the NIH Guide for Grants and Contracts

Notice NOT-HL-19-688 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-19-229 from the NIH Guide for Grants and Contracts. The goals of this Funding Opportunity Announcement (FOA) are to support the development of new or improved informatics tools and methods for the reuse of shared data in the immunology study repository, ImmPort; and to support secondary analyses of existing immunology datasets to address basic and clinical immunology questions.

Notice NOT-AG-19-015 from the NIH Guide for Grants and Contracts